NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Rkmatters,

As to the built in cushion for their screening halt delay I would say this is either odd and there will be another delay or boldly confident that the bases are covered and a favorable resolution is expected by October. I have stated my belief that protocols may have mesenchymal GBM covered. The resizing may even have had something to do with this. If NWBO kept biomarker records for all patients screened or nearly all patients screened, as I suspect they might have since about 2011-2012, then blinded analysis and randomization based on patient characteristics is possible if the company has remained blinded to data. Remember that little hint about data being submitted regarding screening criteria a while back? I think regulators have quite a bit of information on their plates right now.